D
uring development, the segmented paraxial mesoderm of the somites gives rise to different mesodermal derivatives. As somites mature, cells delaminate from the dorsal dermomyotome to form the skeletal muscle of the myotome and later trunk muscles, or migrate from the hypaxial dermomyotome into the early limb bud to form limb muscles (1) . Vascular progenitors also derive from this part of the dermomyotome. In the chicken embryo, a subpopulation of endothelial cells and myogenic progenitors in the trunk (2) and the limb (3) arise from the same multipotent cells in the somite, as do skeletal muscle and vascular smooth muscle of some blood vessels in the trunk (2) . Clonal analysis in the mouse has shown that smooth muscle cells of the dorsal aorta and the myotome have a common origin (4) . Dermomyotomal cells are marked by Pax3, which is essential for the migration of myogenic progenitors to sites of skeletal muscle formation, such as to the limb (1) . Genetic tracing experiments confirm that some endothelial cells in the mouse limb derive from Pax3
+ cells in the somite (5) . Reciprocal inhibition between Pax3 and Foxc2 in the somite, when perturbed genetically in the mouse embryo, affects vascular versus myogenic cell fate choices (6) . Signaling molecules impact the somite, potentially changing the Pax3:Foxc2 equilibrium. In the chicken embryo, manipulation of bone morphogenetic protein signaling showed that it promotes an endothelial cell fate, whereas Notch signaling promotes the formation of vascular smooth muscle at the expense of skeletal muscle (2) . However, in another report on the chicken embryo, overactivation of Notch signaling was shown to increase the migration of vascular endothelial cells from the somite to the dorsal aorta (7) . Notch signaling is active in the hypaxial region of the chick somite (2) and also in somites and in endothelial cells of blood vessels at embryonic day (E) 9.5 in the mouse embryo (7, 8) .
To examine the role of Notch signaling in the myogenic versus endothelial fate choice in the mouse embryo, we have targeted one allele of Pax3 with a sequence coding for NICD, the constitutively active intracellular domain of Notch receptor 1. In the trunk of such Notch gain-of-function embryos, both vascular smooth and endothelial cells derived from the somite are increased, whereas myogenesis is diminished. In the limbs, fewer
Pax3
+ cells are present initially, reflecting the promotion of an endothelial versus skeletal muscle cell fate. Somite explant experiments confirm this shift in cell fate, which is accompanied by an increase in Foxc2 expression, whereas when Notch signaling is inhibited, the reverse is observed with a relative increase in myogenic cells. We conclude that the endothelial/myogenic cell fate choice takes place in Pax3
+ cells in the somite, before their migration to the limbs, and is regulated by the Notch signaling pathway which affects the Pax3:Foxc2 genetic equilibrium.
Results
The Notch Pathway Promotes a Vascular Fate in the Trunk. To determine the role of the Notch pathway in cell-fate decisions in Pax3
+ cells in the mouse somite, we designed a mouse model where a sequence encoding the activated intracellular domain of Notch receptor 1 (NICD) was introduced into the first exon of the Pax3 gene (Fig. S1A) . The floxed Pax3 NICD-IRESnLacZ allele was activated by crossing with a PGK-Cre transgenic line, unless otherwise stated. Expression of NICD1 and Notch target genes, Hey1 and Lunatic fringe, was increased at sites of myogenesis, notably in Significance During embryonic development, multipotent stem cells progressively acquire specific cell fates. The somite is an embryological structure that gives rise to different mesodermal cell types, including skeletal muscle and vascular cells of blood vessels. We show by genetic manipulation that the Notch signaling pathway promotes a vascular cell-fate choice at the expense of skeletal muscle in the mouse somite. Pax3
+ cells in the adjacent somites give rise to myogenic and endothelial cells in the limbs. Gain-of-function or inhibition of Notch signaling affects this cell-fate choice prior to the migration of these somite-derived cells into the limb. This embryological role of Notch is of potential therapeutic relevance to deriving stem cells for tissue repair.
the hypaxial somite, in Pax3 NICD-IRESnLacZ/+ (Pax3
) compared with control embryos (Fig. S1 B and C) . Comparison of β-Galactosidase (β-Gal) activity between Pax3
IRESnLacZ/+ (Pax3 ILZ/+ ) (9) and Pax3 NICD-IRESnLacZ/+ (Pax3
) embryos showed expression at similar sites, reflecting the expression of Pax3 (Fig.  1A) . Pax3 NICD/+ embryos have embryonic defects at sites of Pax3 expression in the neural tube and somites, resulting in developmental defects, which are different from those of Pax3-null embryos. We detected differences in thoracic somites at E11.5, when the organization of Pax3 + cells in the hypaxial dermomyotome is perturbed (Fig. S2A) .
We first examined the effect of the Pax3 NICD allele on vascular cell versus myogenic cell fates in the trunk in somite explant cultures (6) . After 3-d culture of presomitic mesoderm and immature somites isolated from E9.5 embryos in the presence of NICD, transcripts of Myogenin (Myog) were lower, whereas transcripts of Tie2 and Foxc2 that mark vascular cells were significantly higher (Fig. 1B) , as was the expression of Pecam-1 (Fig. S3A) , a marker of differentiated endothelial cells. In vivo, quantitative RT-PCR (qRT-PCR) analysis of immature posterior somites of E11.5 embryos shows up-regulation of Foxc2 and down-regulation of Pax3, as well as the myogenic regulatory genes Myf5 and Myog, in Pax3 NICD/+ embryos compared with controls (Fig. S3B) .
Using genetic tracing with Pax3 Cre and Rosa26
tomato-floxGFP alleles, we show that cells that have expressed Pax3 give rise to both endothelial and smooth muscle cells of the intersomitic vessels (Fig. S4A ) that are formed from sprouting of the aorta. This finding is in keeping with GFP perduration seen in all smooth muscle cells of the dorsal aorta in Pax3 GFP/+ embryos (4). To avoid any contribution of neural crest cells, which also express Pax3 (1) and can contribute to the formation of vascular cells, we used the Myf5
Cre allele, which is first activated in a subset of cells in the presomitic mesoderm (10) . Myf5
Cre/+ ;Rosa26 tomato-floxGFP/+ embryos have scattered GFP + cells within the dermomyotome (Fig.  S4B) . At E10.5, a subpopulation of endothelial and smooth muscle cells of the dorsal aorta are labeled in this experiment (Fig. 1C) NICD/+ embryos. There is a significant increase of the contribution to the aorta of smooth muscle (Fig. 1D ) and endothelial cells (Fig. 1E) derived from the somite. This accumulation of vascular cells induces intersomitic vessel disorganization later as shown by Pecam-1 whole-mount staining in the tail of Pax3 NICD/+ embryos at E12.5 (Fig. S5 ).
In conclusion, these results show that in the mouse embryo, the Notch pathway promotes acquisition of a vascular cell fate in Pax3 + cells. The choice of cell fate probably occurs early during development, because we have observed GFP + cells at E9.25 in the dorsal aorta of Myf5
Cre/+ ;Rosa26 tomato-floxGFP/+ embryos (Fig. S4B ).
Somite-Derived Endothelial and Myogenic Cells in the Limbs. We then analyzed the contribution of Pax3 + cells of the somite to the limb. As previously described (5), cells that have expressed Pax3 give rise to endothelial cells, of the superficial vessels (Fig. S4C) as well as to skeletal muscles of the limb. No smooth muscle cells in the limb were labeled in this experiment, indicating that in the mouse embryo they do not derive from the somite (Fig. S4C ). Cell labeling with GFP in the limbs of Myf5
Cre/+ ;Rosa26 tomato-floxGFP/+ embryos at E10.5 confirms that endothelial as well as myogenic cells derive from the somite, excluding the implication of neural crest cells (Fig. S4D) .
In the absence of Pax3, myogenic progenitors do not migrate to the limbs and no β-Gal + cells are present in Pax3 nLacZ/nLacZ embryos compared with Pax3 nLacZ/+ embryos ( Fig. 2A) . However, in Pax3
Cre/Cre ;Rosa26 floxnLacZ/+ embryos, cells that had expressed Pax3 are present ( Fig. 2A) . In addition to showing that migration of endothelial cells is Pax3-independent, this result also indicates that endothelial cells have migrated from the somites to the forelimbs before apoptosis of cells in the hypaxial dermomyotome, seen by E10.5 in the Pax3 mutant (1).
Once myogenic progenitors are specified in the dermomyotome, they begin to delaminate at E9.25 and migrate into the forelimb at E9.5. We observed at the beginning of the migration that somite-derived endothelial cells, labeled by β-Gal, have already acquired an endothelial cell fate, as shown by Pecam-1 labeling and the absence of Pax3 (Fig. 2B) . At E9.25, we observed by using genetic tracing with Myf5
Cre and Rosa26 tomato-floxGFP alleles, that GFP + cells localized in the hypaxial dermomyotome express both Pax3 and Flk1 proteins (Fig. 2 C, a) . Flk1 is an early marker of endothelial cells. We therefore propose that these cells are bipotent progenitors able to give rise to both endothelial and myogenic cells. When somitic cells leave the hypaxial dermomyotome, cells that maintain Pax3 expression are no longer Flk1 + , whereas cells maintaining Flk1 are no longer Pax3 + (Fig. 2 C, b ). These observations suggest that Flk1 is extinguished in Pax3 + myogenic cells once they have left the somite and that the loss of Pax3 expression is a characteristic of cells that have entered the endothelial lineage.
In conclusion, these results suggest that bipotent progenitors in the hypaxial dermomyotome, which give rise to both endothelial and myogenic cells in the limb, undergo a cell fate choice before they leave the somite. Fig. S6 B and C) , which label migrating myogenic progenitors. In keeping with previous reports on the role of Notch signaling in myogenesis (11, 12) , we observed that Myod1 was not activated initially in the remaining Pax3 + cells in the limbs of Pax3 NICD/+ embryos (Fig. S6D) . Because Pax3 is down-regulated at E12.5, myogenic cells that are now Pax7 + (Fig. S6E) show hyperproliferation rates and also accelerated myogenic differentiation in Pax3 NICD/+ embryos, compared with controls (Fig. S6 F and G) . By E18.5 skeletal muscle masses are indistinguishable from controls (Fig. S6H ). These observations complement those on Notch loss-of-function embryos, illustrating the inhibitory effect of Notch signaling on the entry of progenitor cells into the myogenic program. The findings also demonstrate the plasticity of the myogenic process, so that skeletal muscle formation recovers once a developmental perturbation is lifted.
The Notch Pathway Promotes an Endothelial Cell Fate. This effect on skeletal muscle differentiation occurs once myogenic progenitors have reached the limbs and does not explain why the number of these progenitors is initially reduced in Pax3 NICD/+ embryos. At E9.5-10.5, there is no detectable cell death or structural defect in the hypaxial dermomyotome of these embryos (Fig. S2B) . We therefore investigated whether there had been a corresponding increase in somite-derived endothelial cells in the limbs. The decrease in Pax3 and Myf5 transcripts is accompanied by an increase in Foxc2 transcripts, in keeping with an increase of vascular cells in the forelimbs of Pax3 NICD/+ embryos (Fig. 3A) . Immunohistochemistry on whole embryos with a Pecam-1 antibody showed increased labeling with this endothelial marker at E11.5 compared with the control (Fig. 3B) . Serial confocal images from the dorsal superficial layer to the center of the forelimb showed that this increase is most marked in the superficial region of Pax3 NICD/+ embryos (Fig. S7) , where genetic tracing experiments had shown preferential location of somite-derived endothelial cells (5 (Fig. 3C ). There is a significant increase of the contribution of somitic progenitors to the endothelial, at the expense of the myogenic lineage, when Notch signaling is stimulated.
Notch Affects the Cell Fate of Limb Progenitors in the Somite. Lbx1 activation in the hypaxial dermomyotome of the somite marks myogenic progenitor cells that will migrate into the limbs (1). In Pax3 NICD/+ embryos at E9.25, Lbx1 transcripts are notably reduced compared with the control, indicating an early defect of myogenic specification in the somite (Fig. 4A) . To determine when this defect occurs during development, instead of using the PGK-Cre line, we crossed Pax3 NICD/+ and Rosa26
Cre-ERT2/Cre-ERT2 mice to induce the overexpression of Notch by tamoxifen induction, specifically in Pax3 + cells, at different times during development (Fig. 4B) . When Notch overexpression was induced after E7. + cells in and around the hypaxial dermomyotome, than in the control embryo (Fig. 4C) . Furthermore, in Pax3 NICD/+ embryos the percentage of cells expressing Foxc2 and Flk1 is significantly higher (Fig. S8) . These results indicate that the balance between specification of endothelial cells and myogenic cells in the hypaxial dermomyotome at forelimb level is affected by the Notch pathway, which promotes the endothelial fate.
Finally, to complement these Notch gain-of-function experiments, we used loss-of-function strategies. To inactivate the Notch pathway, we conditionally deleted RBPJ-κ using Pax3 but because of RBPJ-κ stability, protein depletion was not efficient in the critical time window when the cell-fate decision occurs between myogenic and endothelial lineages (Fig. S9 ).
Deletion by Cre-recombinase under the control of genes expressed earlier than Pax3 results in somite defects. We therefore developed the strategy of Notch depletion by the γ-secretase inhibitor, DAPT, on explants of forelimb buds and adjacent somites isolated from wild-type embryos at E8.75 (Fig. 4D ). After 24-h culture, qPCR analysis showed a down-regulation of the Notch target gene, Hey1, and an increase in the ratio of transcripts for Pax3/Foxc2, Lbx1/Flk1, and Myf5/Pecam-1, compared with control explants (Fig.  4D) . These loss-of-function experiments therefore confirm that the Notch signaling pathway acts on the balance between Pax3 and Foxc2 and promotes an endothelial, at the expense of a myogenic cell fate.
Discussion
In the experiments reported here, we characterize somite-derived endothelial cells in the limb and go on to show that increased Notch signaling in Pax3 + progenitors in the somite promotes the endothelial versus myogenic cell fate of these cells.
Endothelial, but not smooth muscle, cells that have migrated from the somite are present in the limb and contribute to blood vessels, particularly to those located superficially, consistent with previous findings (5) . On the other hand, in the trunk smooth muscle cells of the dorsal aorta derive from the somites (4), and we now show for the mouse embryo that endothelial cells of the dorsal aorta are also somite-derived, as previously reported for the chick. Endothelial cells of somitic origin in the limb already express Pecam-1, indicating that they are no longer multipotent and indeed they no longer express Pax3 and do not depend on Pax3 for their migration, in contrast to myogenic progenitors. This finding is in keeping with the observation that endothelial (5), unlike myogenic, cell migration does not depend on the expression of the c-met gene, which is a Pax3 target (1). In the Pax3 mutant, the hypaxial domain of the somite is compromised by apoptosis; however, this occurs later (1), after endothelial cells are detected in the limb at E9.5. Before expression of the endothelial cell-marker Pecam-1, most cells in the hypaxial somite express Flk1. These cells are also Pax3
+ and express Lbx1. Subsequently, Flk1 is present in cells that do not express Pax3, whereas cells that retain Pax3 as they leave the somite are Flk1 Notch loss-of-function embryos (11, 12) where myogenesis was accelerated, with depletion of the progenitor cell population. As Pax3 NICD is down-regulated during development, compensatory mechanisms operate, providing a striking example of developmental plasticity that permits the skeletal muscle mass to attain a normal size.
In the somites of Pax3 NICD/+ embryos, we observe up-regulation of Foxc2 and of vascular markers with an increased contribution of somite-derived smooth muscle and endothelial cells to the dorsal aorta. In the chicken embryo, Notch signaling was reported to promote a smooth-muscle cell fate in multipotent progenitors in the dermomyotome (2). Our results indicate that the endothelial versus myogenic cell fate is also Notchdependant in the mouse somite. This finding does not exclude that bone morphogenetic protein signaling, known to inhibit myogenesis (13) , is not also implicated in this cell-fate choice, as shown in the chick (2) . There is a striking reduction in Pax3 + myogenic progenitors in the limbs of Pax3 NICD/+ embryos and an increased contribution of somite-derived endothelial cells. In the somites at forelimb level and in somite explants, changes in endothelial versus myogenic markers are already detectable. This finding points to a cell-fate choice, influenced by Notch signaling that occurs already in the somite, contrary to what had previously been suggested (5) . The early labeling with endothelial markers and loss of Pax3, as well as the time frame in which activation of the NICD allele affects somite-derived cells in the limb, are in keeping with an early cell-fate choice in the somite, where bipotent endothelial and myogenic progenitors are present (Fig.  5 ). These observations, based on Notch gain-of-function, are complemented by experiments on explants where inhibition of the Notch pathway results in converse effects at the level of endothelial versus myogenic cell fate choices, accompanied by changes in Pax3/Foxc2 transcripts, consistent with the pivotal role of the equilibrium in cell-fate choices (6) . Downstream effects on myogenesis are also consistent with the impact of down-regulation of Notch signaling on muscle cell differentiation (11, 12) . We therefore conclude that the Pax3 NICD allele is affecting an existing process rather than creating an artificial situation.
In conclusion, stimulation of Notch signaling in Pax3 + cells results in an increase in the number of endothelial cells and a reduction in the number of myogenic cells that migrate into the limbs. This cell-fate change takes place in the Pax3 + cells of the somite that can give rise to both derivatives, and is accompanied by a change in the expression of Pax3 versus Foxc2 which promote myogenic versus endothelial cell fates, respectively. (14), and an IRES-nLacZ cassette with an SV40 pA sequence was introduced into exon1 immediately after the 5′ UTR (Fig. S1A) . CreERT2/+ mice at 2 mg per pregnant female (30 g).
Methods
X-Gal Staining, in Situ Hybridization, and Immunodetection. X-Gal staining, after 15-min fixation and whole-mount in situ hybridization with digoxigenin-labeled probes, was carried as previously described (6 Quantification by Acapella Software. Image analysis was performed using scripts developed in Acapella Image analysis software (v2.3; Perkin-Elmer Technologies). Scripts successively segment in the appropriate channels (red and green), with their respective associated features (number, size, intensity). From this segmentation, two binary masks were performed to retain the location of each cell. The script then compares the cells present in both channels by locating the recovery of the two binary masks (for the proliferation study) or the nonrecovery (for the differentiation study). Explant Culture. Explant experiments with presomitic mesoderm/early somites (interlimb level at E9.5) or with somites and forelimb buds (E8.75) were carried out as described in refs. 6 and 23, respectively. DAPT in DMSO (Calbiochem) was added at 50-μM final concentration, with DMSO alone added to control cultures.
Quantification of Contribution of Somitic
qRT-PCR Analysis. Total RNA was prepared by using TRIzol reagent (Invitrogen) or with the RNeasy Mini Kit (Qiagen). RNA was reverse transcribed using the SuperScript II kit (Invitrogen) or the QuantiTect Reverse Transcription Kit (Qiagen) and real-time PCR, as described in ref. 6 . Primer sequences are listed in SI Methods.
Statistics. All experiments were carried out on a minimum of three embryos. Data have been analyzed with the Mann-Whitney nonparametric test, using Anastats files (http://www.anastats.fr). The Student t test was applied, preceded by the Fisher's test. Data are presented as the mean and SEM.
